• Twitter
  • Search
e-axes

360° Econ View

The issues, the debates, and the research

  • Home
  • Useful Data
  • About
  • Contact
  • Home
  • Useful Data
  • About
  • Contact

COVID-19

Coronavirus in Europe

Posted by e-axes on March 17, 2020

Read Next →

COVID-19

Navigating ESG Reputational Risks

COVID-19

Policy lessons from the pandemic

COVID-19

The economics of vaccines

“The adequate policy response depends on the phase”

Phase 3 – acute overall disruption (starting early March in Italy, 1-3 weeks later in other European countries): aggregate supply shock resulting from contagion containment measures with restrained demand and mobility. […] In the event of a one-month lockdown leading to a temporary 50% drop in private-sector activity, we estimate that the cost of exceptional support measures would amount to 0.5% to 1% of annual GDP.

Phase 4 – recovery (starting in May or June): a sharp rebound is likely but may be muted by hysteresis due to confidence effects, lost corporate income in the service sectors, bankruptcies among SMEs and credit constraints resulting from the accumulation of non-performing loans on banks’ balance sheets and the rebuilding of dented savings at the household level. […] The priority in this phase will be on aggregate demand rather than supply-side or sectoral measures. The most appropriate vehicle is likely to be direct transfers to households. There is a need to plan the boost beforehand so that it can be activated at the right moment. Again, the European dimension will be key to internalising externalities.

COVID-19: Europe needs a catastrophe relief plan
By: Agnès Bénassy-Quéré, Ramon Marimon, Jean Pisani-Ferry, Lucrezia Reichlin, Dirk Schoenmaker, Beatrice Weder di Mauro – University of Paris 1 Panthéon-Sorbonne, European University Institute, London Business School, Erasmus University, Graduate Institute of Geneva

Reconsidering Eurobonds?

A Eurozone ‘Coronavirus’ bond would send a strong signal that European countries stand behind the weakest of their member when confronted by a common shock. It will be more powerful than monetary policy contortions in restoring economic confidence and enabling the health authorities in all the affected European countries to fight the real battle. Should a targeted Eurobond issuance prove a bridge too far for European policymakers, there is an alternative. A coordinated jumbo sovereign debt issuance -between 10% to 20% of GDP-coordinated with an expansion of Quantitative Easing by the ECB would provide much needed fiscal space.

Flattening the Pandemic and Recession Curves
By: Pierre-Olivier Gourinchas – UC Berkeley

The case for an “insurance fund”

Yet, at present, it has no instrument in place to support member countries amid large common shocks. The European Stability Mechanism could be activated in an extreme scenario, but using it as a demand-management tool would be inappropriate. And the EU Solidarity Fund is too small for the job.The COVID-19 pandemic thus represents an opportunity for the EU to create a powerful crisis-management mechanism, which pools member states’ resources and channels them toward a coordinated fiscal policy. The idea of such an “insurance fund” is not new: several economists championed the idea after the last crisis, when discussion of governance reform was in full swing.

COVID-19 Is an Opportunity for Europe
By: Lucrezia Reichlin – London Business School.

Many questions for the future

The pandemic could trigger a rethink of global economic exposures and production patterns. Will companies decide to increase stocks to be better equipped in the future to deal with supply chain disruptions? Will they reduce the length of value chains to become less vulnerable to such shocks? And how will international travel be transformed? As always, such a crisis is also an opportunity to revisit business models and, perhaps also in consideration of the threat to the climate, to reassess international mobility. […] The EU should also intensify its support to the development of medication and vaccines, true public goods, where the incentives for private pharmaceuticals companies might be insufficient.


An effective economic response to the Coronavirus in Europe
By: Maria Demertzis, André Sapir, Simone Tagliapietra, Guntram B. Wolf – Bruegel

Print Friendly, PDF & Email

e-axes

Read Next →

COVID-19

Navigating ESG Reputational Risks

COVID-19

Policy lessons from the pandemic

COVID-19

The economics of vaccines

Comments are Closed

Account

  • Login

Subscriptions

You are not logged in.
Login
Subscribe

Subscriptions

Subscribe

Most Read

  • Gold, the Dollar, and the Geopolitics of Global Reserves
  • From Information to Liquidity: How Stablecoins Reshape Bank Intermediation
  • China and the Political Economy of Critical Minerals
  • Public Debt Maturity and Macroeconomic Policy Transmission
  • Bank Heterogeneity and the Transmission of Monetary Tightening
  • AI, Knowledge and the Future of Human Expertise
  • New and Noteworthy Books in Economics (September)
  • AI Valuations, Capital Investment, and Growth
  • AI and the Natural Rate: Puzzle or Policy Challenge?
  • Fertility Falls Everywhere But Will Growth Suffer?

Sections

  • AI
  • Banking
  • Books
  • Brexit
  • CBDC
  • China
  • Climate
  • COVID-19
  • Crypto
  • Demographics
  • Economic Growth
  • Economic Science
  • Economics of Information
  • Emerging Markets
  • Eurozone
  • Financial Markets
  • Geoeconomics
  • Geopolitics
  • India
  • Inequality
  • Inflation
  • International Economics
  • Macro
  • Markets
  • Monetary Policy
  • Oil
  • Politics & Economics
  • Taxation
  • Tech
  • Trade
  • U.S.
  • Ukraine-Russia War
  • Uncategorized
  • Useful Data

© 2026 e-axes

  • Privacy Policy & Terms of Service

Theme by Anders Norén

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.
Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are as essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
SAVE & ACCEPT